Effect of Omalizumab in the Skin of Food Allergy Patients (NCT06618963)
🩺 Plain-English Summary (8th-Grade Level)
The goal of this interventional study is to evaluate whether skin barrier abnormalities occur in subjects with a food allergy, as determined by positive oral food challenge (OFC). The main question it aims to answer is whether these skin barrier abnormalities can be reversed by omalizumab. If there is a comparison group: Researchers will compare non-food allergic participants (who do not receive omalizumab) to see if they experience skin barrier abnormalities. All food allergic participants will receive 4 months of Omalizumab treatment as well as two Oral Food Challenges. Participants will all undergo skin barrier assessments.
Who can join: Review the eligibility criteria below.
Location: National Jewish Health — Denver, Colorado
Age range: 1 Year to 55 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- National Jewish Health — Denver, Colorado
📞 Contact the Study Coordinator
Phone: (303) 398-1409
Email: leungs@njhealth.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Food Allergy
- Short-Term Linvoseltamab Treatment on Top of Chronic Dupilumab Treatment for Adults With Severe Immunoglobulin E (IgE)-Mediated Food Allergy — Tampa, Florida
- FeNO as a Marker of Allergic Reactions to OFC and Response of OMA Treatment in Multiple FA — Coral Gables, Florida
- Prescreening Protocol to Enroll in Food Allergy Clinical Studies at a Single Site — Palo Alto, California
- Natural History and Genetics of Food Allergy and Related Conditions — Bethesda, Maryland
- Early Introduction and Sustained Ingestion (EISI) Using Two Educational Opportunities in Infants — Stanford, California
Explore by condition: All Food Allergy clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.